Kyverna Therapeutics, Inc. Common Stock — Institutional Ownership

Which tracked institutions hold KYTX, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.

18
Funds holding
$101364825
Total value held
Buying
15 added/new · 1 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Gilead Sciences, Inc. $36763720 4126119 Held
2 Blackrock, Inc. $27931130 3134807 +2257729 +257.41%
3 Morgan Stanley $8752355 982307 +5018 +0.51%
4 State Street Corp $8751696 982233 +843933 +610.22%
5 Wells Fargo & Company/Mn $3323510 373009 +258610 +226.06%
6 Ubs Group Ag $3257264 365574 +365574 NEW BUY
7 Goldman Sachs Group Inc $2986899 335230 +122320 +57.45%
8 Northern Trust Corp $2809805 315354 +237312 +304.08%
9 Bank Of America Corp /De/ $2364759 265405 +209677 +376.25%
10 Stifel Financial Corp $1247088 139965 +139965 NEW BUY
11 Barclays Plc $1049991 117844 -18531 -13.59%
12 Bank Of New York Mellon Corp $893504 100281 +100281 NEW BUY
13 Invesco Ltd. $497240 55807 +55807 NEW BUY
14 Federated Hermes, Inc. $273582 30705 +30705 NEW BUY
15 Jpmorgan Chase & Co $201805 22984 +18309 +391.64%
16 Citigroup Inc $185845 20858 +8561 +69.62%
17 Royal Bank Of Canada $61000 6877 +4329 +169.90%
18 Pnc Financial Services Group, Inc. $13632 1530 Held

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.